CREBBP alterations are associated with a poor prognosis in de novo AML. Lamble AJ, Hagiwara K, Gerbing RB, Smith JL, et al. Blood 2023;141:2156-2159.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lamble AJ, Hagiwara K, Gerbing RB, Smith JL, et al. CREBBP alterations are associated with a poor prognosis in de novo AML. Blood 2023;141:2156-2159.
PMID: 36634304